PDG19 COST-EFFECTIVENESS OF OBINUTUZUMAB-CHEMOTHERAPY FOLLOWED BY OBINUTUZUMAB MAINTENANCE COMPARED TO RITUXIMAB-CHEMOTHERAPY FOLLOWED BY RITUXIMAB MAINTENANCE IN A CHILEAN HEALTH PUBLIC SYSTEM SETTING FOR NON-HODGKIN-LYMPHOMA PATIENT’S
May 1, 2020, 00:00
10.1016/j.jval.2020.04.309
https://www.valueinhealthjournal.com/article/S1098-3015(20)30497-6/fulltext
Title :
PDG19 COST-EFFECTIVENESS OF OBINUTUZUMAB-CHEMOTHERAPY FOLLOWED BY OBINUTUZUMAB MAINTENANCE COMPARED TO RITUXIMAB-CHEMOTHERAPY FOLLOWED BY RITUXIMAB MAINTENANCE IN A CHILEAN HEALTH PUBLIC SYSTEM SETTING FOR NON-HODGKIN-LYMPHOMA PATIENT’S
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30497-6&doi=10.1016/j.jval.2020.04.309
First page :
Section Title :
Open access? :
No
Section Order :
10170